Solventum (SOLV) reported $8.3B in revenue for fiscal 2025, +0.9% year on year. That ranks #565 by revenue among 2853 SEC filers and #56 in Healthcare. Net income was $1.6B, a net margin of 18.7%. Revenue has grown 0.8% a year on average since 2022 ($8.1B then). The fiscal 2025 balance sheet shows $14.3B in total assets, $878M in cash and $5.0B in long-term debt.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenues | $8.3B | +0.9% | FY20252025-12-31 |
| Gross profitGrossProfit | $4.5B | −3.1% | FY20252025-12-31 |
| Operating incomeOperatingIncomeLoss | $2.2B | +110.5% | FY20252025-12-31 |
| Net incomeNetIncomeLoss | $1.6B | +224.8% | FY20252025-12-31 |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $369M | −68.9% | FY20252025-12-31 |
| Capital expenditurePaymentsToAcquirePropertyPlantAndEquipment | $379M | −0.3% | FY20252025-12-31 |
| Total assetsAssets | $14.3B | −1.1% | FY20252025-12-31 |
| Shareholders' equityStockholdersEquity | $5.0B | +70.6% | FY20252025-12-31 |
| CashCashAndCashEquivalentsAtCarryingValue | $878M | +15.2% | FY20252025-12-31 |
| Long-term debtLongTermDebtNoncurrent | $5.0B | −35.5% | FY20252025-12-31 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Reported since the last full year
Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.
| Quarter | Revenue | Net income | Source |
|---|---|---|---|
| Q1 20262026-03-31 | $2.0B | $13.0M | Open → |
| Q2 20262026-06-30 | $2.2B | $92.0M | Open → |
Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.
Where this sits in its sector
Each bar is the spread of the whole sector: the box covers the middle half of companies, the line inside it the median, and the triangle this company. The axis is clipped at the 5th and 95th percentile so a single outlier does not flatten it.
| Where this sits in its sector | FY2025 | Position in sector |
|---|---|---|
| Net marginRank 25 of 161 companies compared | 18.7% | |
| Operating marginRank 22 of 160 companies compared | 26.2% | |
| R&D as share of revenueRank 49 of 102 companies compared | 8.9% | |
| Cash as share of revenueRank 82 of 160 companies compared | 10.5% |
All four are ratios derived from two reported lines, not single filing items. Peer group: companies in the same sector with revenue of $1bn or more; loss-making companies are included.
Profile
- Legal name
- Solventum Corp
- Ticker
- SOLV
- Exchange
- NYSE
- SIC classification
- Surgical & Medical Instruments & Apparatus (3841)
- Fiscal year end
- 12-31
- CIK
- 0001964738
Filings
- 10-QAug 5, 2026Open filing →
- 10-QMay 5, 2026Open filing →
- 10-KFeb 27, 2026Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| Intuitive SurgicalISRG | $10.1B | $2.9B |
| BiogenBIIB | $9.9B | $1.3B |
| ZoetisZTS | $9.5B | $2.7B |
| SolventumSOLV | $8.3B | $1.6B |
| IconICLR | $8.3B | $229M |
| Zimmer BiometZBH | $8.2B | $705M |
| Ardent HealthARDT | $6.3B | $136M |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Solventum — Key figures |url=https://companiesranked.com/en/company/solventum |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Solventum — Key figures. CompaniesRanked. https://companiesranked.com/en/company/solventumBibTeX
@misc{companiesranked-en-company-solventum-2026,
author = {{CompaniesRanked}},
title = {{Solventum — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/solventum}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001964738-26-000007 · February 27, 2026
{{cite web |title=Solventum — Key figures — 10-K (0001964738-26-000007) |url=https://www.sec.gov/Archives/edgar/data/1964738/000196473826000007/solv-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-27}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.